Early initiation of angiotensin-converting enzyme inhibitors in postrenal transplant period: A study from a state-run tertiary care center
Angiotensin-converting enzyme inhibitors (ACEi) comprise a drug class, which are potent antihypertensives with renoprotective effects but are grossly underutilized in renal transplant recipients. These drugs have been reported to cause elevated potassium and creatinine levels in some renal transplan...
Main Authors: | C G Sreeadhara, Raghavendra Narayanaswamy, Umesh Lingaraju, V Leelavathi, S M Shivaprasad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=3;spage=637;epage=642;aulast=Sreeadhara |
Similar Items
-
Thrombotic microangiopathies postrenal transplantation
by: Kartik Ganesh, et al.
Published: (2020-01-01) -
Haematuria in Postrenal Transplant Patients
by: Ziting Wang, et al.
Published: (2015-01-01) -
Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014-03-01) -
Prevalence of hypertension in postrenal transplant recipients: A retrospective tertiary care study
by: Georgi Abraham, et al.
Published: (2017-01-01) -
Studies on the inhibitors of angiotensin converting enzyme
by: Hodsman, G. P.
Published: (1983)